🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

10 recruiting trials

for Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) NCT07179380Phase 3186 sites📍 Phoenix📍 Fresno📍 Los Angeles Insmed Incorporated · Tests: Treprostinil Palmitil Inhalation Powder, Placebo A Clinical Trial of NS-863 in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) NCT07441278Phase 22 sites📍 Knoxville📍 Kitakyushu NS Pharma, Inc. · Tests: NS-863 Low Dose, NS-863 High Dose, Placebo A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY) NCT07175038Phase 224 sites📍 Phoenix📍 Rancho Cordova📍 Aurora AllRock Bio, Inc. · Tests: ROC-101 A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD NCT07333183Phase 213 sites📍 Santa Barbara📍 Torrance📍 Kissimmee Pulmovant, Inc. · Tests: inhaled mosliciguat, Dry Powder Inhaler Study to Evaluate Safety and Efficacy of Mirivadelgat in PH-ILD (Windward) NCT06475781Phase 211 sites📍 Banja Luka📍 Sarajevo📍 Hualien City Foresee Pharmaceuticals Co., Ltd. · Tests: Mirivadelgat, placebo DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) NCT06388421n/a71 sites📍 Birmingham📍 Phoenix📍 Los Angeles United Therapeutics · Tests: Prospective study assessments An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) NCT07234032Phase 311 sites📍 Naples📍 Bend📍 Prague Insmed Incorporated · Tests: Treprostinil Palmitil Inhalation Powder, Placebo A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD NCT07285655Phase 344 sites📍 Phoenix📍 Scottsdale📍 Los Angeles Liquidia Technologies, Inc. · Tests: L606, Placebo LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) NCT05798923Phase 24 sites📍 Tucson📍 New Haven📍 Boston IRulya Therapeutics Inc. · Tests: Placebo, LAM-001 A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier) NCT07816185Phase 33 sites📍 Kissimmee📍 Louisville📍 Bend Pulmovant, Inc. · Tests: Mosliciguat, Placebo, Dry Powder Inhaler
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy